Research Article

Homocysteine Level and Risk of Hemorrhage in Brain Arteriovenous Malformations

Table 2

Characteristics of bAVM patients according to Hcy quartiles.

VariablesHcy quartilesa, μmol/L trend
All ()Q1 ()Q2 ()Q3 ()Q4 ()

Age, y, mean (SD)29.6 (14.0)23.8 (16.0)30.2 (13.7)35.4 (12.8)28.9 (10.9)0.005
Sex, male (%)79 (55.2)11 (30.6)17 (48.6)22 (61.1)29 (80.6)<0.001
Medical history (%)
 Hypertension9 (6.3)1 (2.8)2 (5.7)4 (11.1)2 (5.6)0.448
 Diabetes mellitus3 (2.1)0 (0)1 (2.9)1 (2.8)1 (2.8)0.438
 Hyperlipidemia1 (0.7)0 (0)0 (0)1 (2.8)0 (0)0.657
 Cigarette smoking26 (18.2)1 (2.8)6 (17.1)10 (27.8)9 (25.0)0.007
 Alcohol drinking16 (11.2)0 (0)4 (11.4)8 (22.2)4 (11.1)0.060
Primary symptom (%)
 Hemorrhage74 (51.7)21 (58.3)20 (57.1)19 (52.8)14 (38.9)0.093
 Seizure30 (21.0)4 (11.1)6 (17.1)9 (25.0)11 (30.6)0.029
 Neurological dysfunction29 (20.3)8 (22.2)7 (20.0)8 (22.2)6 (16.7)0.629
 Admission (%)15 (10.5)9 (25.0)1 (2.9)2 (5.6)3 (8.3)0.037
 AVM characteristics
 Spetzler-Martin grade (%)0.660
  I-II81 (56.6)17 (47.2)23 (65.7)20 (55.6)21 (58.3)
  III42 (29.4)13 (36.1)8 (22.9)12 (33.3)9 (25.0)
  IV-V20 (14.0)6 (16.7)4 (11.4)4 (11.1)6 (16.7)
 Maximum diameter, cm, median (IQR)3.4 (2.5-4.6)4.0 (2.6-4.7)3.0 (2.5-4.4)3.0 (2.3-3.9)3.7 (2.6-5.1)0.183
 Volume, cm3, median (IQR)8.6 (4.4-25.0)10.9 (5.2-29.7)7.2 (5.0-19.3)8.2 (3.2-17.7)13.9 (4.3-31.8)0.239
 Deep location (%)33 (23.1)8 (22.2)7 (20.0)8 (22.2)10 (27.8)0.549
 Eloquent location (%)72 (50.3)19 (52.8)18 (51.4)19 (52.8)16 (44.4)0.526
 Diffusive nidus (%)68 (47.6)21 (58.3)17 (48.6)10 (27.8)20 (55.6)0.434
 Deep venous drainage (%)43 (30.1)12 (33.3)8 (22.9)13 (36.1)10 (27.8)0.916
 Associated aneurysms (%)21 (14.7)6 (16.7)5 (14.3)6 (16.7)4 (11.1)0.588

bAVM: brain arteriovenous malformation; Hcy: homocysteine; SD: standard deviation; mRS: modified Rankin Scale; IQR: interquartile range. , significant difference. aSerum levels of Hcy in quartiles: Q1, <10.0 μmol/L; Q2, 10.0-12.3 μmol/L; Q3, 12.4-16.1 μmol/L; and Q4, >16.1 μmol/L.